|
Office of Occupational Safety and Health (00S1) Quarterly DASHO Conference Call Agenda October 23, 2001 AGENDA Time: 1 - 1:50 PM Eastern Time
Phone No. (Bridge): 1-800-767-1750 (please use code #15076)
Subject: Terrorism
Audience: All Employees, Union Representatives, and Safety Officials Links to additional information:  | FBI poster on suspicious packages - Adobe file  | | OSHA Interpretations: | | CDC | HOW TO HANDLE ANTHRAX AND OTHER BIOLOGICAL AGENT THREATS | | | | Facts about Anthrax | "Direct person-to-person spread of anthrax is extremely unlikely, if it occurs at all. Therefore, there is no need to immunize or treat contacts of persons ill with anthrax, such as household contacts, friends, or coworkers, unless they also were also exposed to the same source of infection." |
| "For people with suspected anthrax disease, laboratory testing is essential to diagnosis. Tests may include: | Cultures of blood and spinal fluid (should be done before antibiotic treatment has been initiated) | | Cultures of tissue of fluids from affected areas. | | Microscopic examination of tissue. | | PCR (polymerase chain reaction) test that amplifies trace amounts of DNA to document that the anthrax bacteria is present." |
|
| | Clinical and Epidemiologic Principles of Anthrax | "... these spores, at 2-6 microns in diameter, are the ideal size for impinging on human lower respiratory mucosa, optimizing the chance for infection. It is the manufacture and delivery of anthrax spores in this particular size range (avoiding clumping in larger particles) that presents a substantial challenge to the terrorist attempting to use the agent as a weapon." |
|
|
"...history is not necessarily a perfectly linear or continuous progression. There are unpleasant surprises and breakouts, and with biological weapons, you only have to be wrong once." From an interview with Michael L. Moodie, longtime president of the Chemical and Biological Arms Control Institute in Washington Previous DASHO Call on subject
|
